2m 2m 2m 2m 2m 2m 2m
CytomX Therapeut (CTMX)
NASDAQ
$3.18+$0.14 (+4.57%)
Price as of Jun 23, 2026 7:55 PM EDT- $661.8MMarket Cap
- 40.74%1-Year Change
- BiotechnologyIndustry
CytomX Therapeut (CTMX)
$3.18+$0.14 (+4.57%)
CTMX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.04 | ||
Change | +$0.09 (+3.05%) | ||
Open | $2.98 | ||
High | $3.08 | ||
Low | $2.95 | ||
Previous Close | $2.95 | ||
Volume | 3,780,420 | ||
30-Day Average Volume | 4,274,880 | ||
1-Week Change | 0.00% | ||
1-Month Change | -19.15% | ||
1-Year Change | 40.74% | ||
3-Year Change | 100.00% | ||
5-Year Change | -56.13% | ||
Fundamentals | |||
Shares Outstanding | 217.7M | ||
Total Assets | $359.4M | ||
Market Cap | $661.8M | ||
Enterprise Value | $633.0M | ||
Period: QTR TTM FY | |||
Revenue | $10.3M | ||
Net Income | -$18.2M | ||
Free Cash Flow | -$25.5M | ||
EBIT | -$18.2M | ||
EBITDA | -$18.2M | ||
Net Working Capital | $319.1M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -35 | ||
Enterprise Value/Revenue | 62 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue